North America Is Expected To Hold The Dominant Position In The Global Angioedema Treatment Market

Angioedema Treatment

 

Angioedema is a medical condition that causes swelling of the lower layer of skin and tissue just beneath the skin, as well as the mucous membrane. Angioedema is classified into four types: allergic angioedema, drug-induced angioedema, idiopathic angioedema, and hereditary angioedema (HAE). Angioedema is caused by a variety of factors, the majority of which are unknown. Angioedema is caused primarily by allergic reactions, adverse effects of medications, genetic defects, and infections. Haegarda, a C1 Esterase Inhibitor (Human) for subcutaneous administration, was approved by the US Food and Drug Administration in 2017 for the prevention of hereditary angioedema (HAE) in adult and adolescent patients.

 

Europe's Angioedema Treatment Market is expected to grow significantly due to the increasing presence of angioedema drug manufacturers, and it is also expected to grow significantly over the forecast period due to the increasing number of new manufacturing plants in the region. For example, Shire plc received US Food and Drug Administration approval in January 2018 for the technology transfer of the CINRYZE (C1 esterase inhibitor [human]) drug product manufacturing process to the Vienna, Austria manufacturing site. CINRYZE is an injectable prescription medication used to treat HAE in teenagers and adults. Because of the approval of new drugs indicated for the treatment of angioedema, North America is expected to hold the dominant position in the global angioedema treatment market.

 

Shire plc, CSL Limited, Pharming Group NV, Ionis Pharmaceuticals, Inc., iBio Inc., and BioCryst Pharmaceuticals, Inc. are key players in the angioedema treatment market. Shire plc. received European Commission (EC) approval in 2017 for label extension, broadening use of FIRAZYR (icatibant injection) to adolescents and children aged 2 years and older with HAE caused by C1-esterase-inhibitor (C1-INH) deficiency.

Comments

Popular posts from this blog

With the use of High-Frequency alternating current, Radiofrequency Ablation Device convert Electromagnetic Energy into Heat Energy

The Isocyanates Market to Witness Robust Growth in North America and Asia Pacific

Air Purifier works as a Sanitizer in the air which helps in reducing pollutants, allergens, and toxins